Q3 2023 Results - Reimagining Medicine slide image

Q3 2023 Results - Reimagining Medicine

Company overview Financial review Conclusions Appendix References Harry Kirsch Chief Financial Officer Financial review and 2023 guidance 22 Investor Relations | Q3 2023 Results NOVARTIS | Reimagining Medicine
View entire presentation